Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 121 AL 135

Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease

Fonseca-Santos B, Gremião MP, Chorilli M.

Int J Nanomedicine. 2015 Aug 4;10:4981-5003. doi: 10.2147/IJN.S87148. eCollection 2015.

The problem of genotype and sex differences in life expectancy in transgenic AD mice

Rae EA, Brown RE.

Neurosci Biobehav Rev. 2015 Oct;57:238-51. doi: 10.1016/j.neubiorev.2015.09.002. Epub 2015 Sep 6.

Human Kinetic Modeling of the 5HT6 PET Radioligand 11C-GSK215083 and Its Utility for Determining Occupancy at Both 5HT6 and 5HT2A Receptors by SB742457 as a Potential Therapeutic Mechanism of Action in Alzheimer Disease

Parker CA, Rabiner EA, Gunn RN, Searle G, Martarello L, Comley RA, Davy M, Wilson AA, Houle S, Mizrahi R, Laruelle M, Cunningham VJ.

J Nucl Med. 2015 Dec;56(12):1901-9. doi: 10.2967/jnumed.115.162743. Epub 2015 Sep 17.

Understanding the Multifaceted Role of Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2) and its Altered Behaviour in Human Diseases

Cholia RP, Nayyar H, Kumar R, Mantha AK.

Curr Mol Med. 2015;15(10):932-43. doi: 10.2174/1566524015666150921104804.

Potential drug-drug interactions in Alzheimer patients with behavioral symptoms

Pasqualetti G, Tognini S, Calsolaro V, Polini A, Monzani F.

Clin Interv Aging. 2015 Sep 8;10:1457-66. doi: 10.2147/CIA.S87466. eCollection 2015.

A Review of Pharmacological Treatments for Depression in Alzheimer's Disease

Siarkos KT, Katirtzoglou EA, Politis AM.

J Alzheimers Dis. 2015;48(1):15-34. doi: 10.3233/JAD-148010.

Repetitive Transcranial Magnetic Stimulation as an Alternative Therapy for Cognitive Impairment in Alzheimer's Disease: A Meta-Analysis

Liao X, Li G, Wang A, Liu T, Feng S, Guo Z, Tang Q, Jin Y, Xing G, McClure MA, Chen H, He B, Liu H, Mu Q.

J Alzheimers Dis. 2015;48(2):463-72. doi: 10.3233/JAD-150346.

Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

Kubo M, Kishi T, Matsunaga S, Iwata N.

J Alzheimers Dis. 2015;48(3):667-71. doi: 10.3233/JAD-150393.

Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and Interventions

Bhat NR.

J Alzheimers Dis. 2015;46(3):581-91. doi: 10.3233/JAD-150098.

APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease

Waring JF, Tang Q, Robieson WZ, King DP, Das U, Dubow J, Dutta S, Marek GJ, Gault LM.

J Alzheimers Dis. 2015;47(1):137-48. doi: 10.3233/JAD-142589.

Cerebral perfusional effects of 1-year rivastigmine treatment in Alzheimer disease: a case report

Ettorre E, Bersani FS, Colella F, Servello A, Minichino A, Megna V, Liberatore M, Biondi M, Marigliano V.

Riv Psichiatr. 2015 Jul-Aug;50(4):188-91. doi: 10.1708/2002.21650.

[Molecular aspects of the pathogenesis and current approaches to pharmacological correction of Alzheimer's disease]

Kukharsky MS, Ovchinnikov RK, Bachurin SO.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(6):103-114. doi: 10.17116/jnevro20151156103-114.

Can Chinese Herbal Medicine Adjunctive Therapy Improve Outcomes of Senile Vascular Dementia? Systematic Review with Meta-analysis of Clinical Trials

Zeng L, Zou Y, Kong L, Wang N, Wang Q, Wang L, Cao Y, Wang K, Chen Y, Mi S, Zhao W, Wu H, Cheng S, Xu W, Liang W.

Phytother Res. 2015 Dec;29(12):1843-57. doi: 10.1002/ptr.5481. Epub 2015 Oct 6.

Possibility of Acetylcholinesterase Overexpression in Alzheimer Disease Patients after Therapy with Acetylcholinesterase Inhibitors

Kračmarová A, Drtinová L, Pohanka M.

Acta Medica (Hradec Kralove). 2015;58(2):37-42. doi: 10.14712/18059694.2015.91.

A MicroRNA-BDNF Negative Feedback Signaling Loop in Brain: Implications for Alzheimer's Disease

Keifer J, Zheng Z, Ambigapathy G.

Microrna. 2015;4(2):101-8. doi: 10.2174/2211536604666150813152620.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias